During the past decade, Centrum Medyczne AMED conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 34 clinical trials were completed, i.e. on average, 64.2% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 28 clinical trials were completed. i.e. 155.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Medyczne AMED" #1 sponsor was "Eli Lilly and Company" with 11 trials, followed by "Galapagos NV" with 9 trials sponsored, "Pfizer" with 6 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored and "Genentech, Inc." with 5 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne AMED" #1 collaborator was "Incyte Corporation" with 5 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Galapagos NV" with 2 trials as a collaborator and "Quintiles, Inc." with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Medyczne AMED" are "Rheumatoid Arthritis" (17 trials), "Psoriatic Arthritis" (5 trials), "Systemic Lupus Erythematosus" (5 trials), "Arthritis, Psoriatic" (3 trials) and "Atopic Dermatitis" (3 trials). Many other conditions were trialed in "Centrum Medyczne AMED" in a lesser frequency.

Most popular intervention types in "Centrum Medyczne AMED" are "Drug" (54 trials), "Biological" (6 trials), "Other" (6 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Baricitinib" (6 trials), "Filgotinib" (5 trials), "Guselkumab" (3 trials) and "filgotinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Medyczne AMED" are 57 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centrum Medyczne AMED". undefined are not yet recruiting, 5 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 36 completed trials in Centrum Medyczne AMED, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Medyczne AMED, 1 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".